We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Zambia Chlorhexidine Application Trial (ZamCAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01241318
Recruitment Status : Completed
First Posted : November 16, 2010
Results First Posted : May 3, 2019
Last Update Posted : August 31, 2020
Sponsor:
Collaborators:
Bill and Melinda Gates Foundation
Ministry of Health, Zambia
Zambia Center for Applied Health Research and Development
Information provided by (Responsible Party):
Boston University

Study Type Interventional
Study Design Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: None (Open Label);   Primary Purpose: Prevention
Condition Sepsis
Interventions Drug: Chlorhexidine gluconate (4%)
Procedure: Dry cord care
Enrollment 77535
Recruitment Details In the 90 clusters (i.e. government-run health facilities), pregnant women who met eligibility criteria attending antenatal care were offered enrollment. Recruitment started February 15, 2011 and ended January 30, 2013.
Pre-assignment Details Mothers were enrolled in the study while pregnant and infants were enrolled after delivery; thus the total protocol enrollment is women + infants. Study reporting is completed at the woman level and thus the total enrolled is listed at the woman level in the outcomes tables.
Arm/Group Title Chlorhexidine Cord Care Dry Cord Care
Hide Arm/Group Description

Mothers located in health facility catchment areas assigned to this arm will apply chlorhexidine to their infants daily until three days after the cord completely separates.

Chlorhexidine gluconate (4%): Chlorhexidine is a topical antiseptic that has long been tested for safety and widely used in developed country hospitals, pre-surgical antiseptic technique, wound cleaning and disinfection. Mothers will be instructed to apply 10 ml of 4% chlorhexidine once a day following the infants bath every day from birth until three days after the cord completely separates from the infant's body.

Mothers in health facility catchment areas assigned to this arm will use dry cord care - keeping their babies' umbilical stumps clean and dry - as per normal routine standard of care and in accordance with Zambia Ministry of Health policy.

Dry cord care: Mothers will be instructed to keep their infants' umbilical cord stumps clean and dry and to not apply any foreign substances to the cord stump.

Period Title: Overall Study
Started 19629 [1] 20050 [1]
Liveborn Infant 18510 [2] 19346 [2]
Completed 18450 [2] 19308 [2]
Not Completed 1179 742
Reason Not Completed
Woman: false pregnancies             27             15
Woman: miscarriage/abortion             46             38
Withdrawal by Subject             175             46
Lost to Follow-up             740             455
Death             2             4
Withdrew/Lost to Follow after delivery             60             38
Woman: Stillborn infant             129             146
[1]
Women enrolled
[2]
Infants
Arm/Group Title Chlorhexidine Cord Care Dry Cord Care Total
Hide Arm/Group Description

Mothers located in health facility catchment areas assigned to this arm will apply chlorhexidine to their infants daily until three days after the cord completely separates.

Chlorhexidine gluconate (4%): Chlorhexidine is a topical antiseptic that has long been tested for safety and widely used in developed country hospitals, pre-surgical antiseptic technique, wound cleaning and disinfection. Mothers will be instructed to apply 10 ml of 4% chlorhexidine once a day following the infants bath every day from birth until three days after the cord completely separates from the infant's body.

Mothers in health facility catchment areas assigned to this arm will use dry cord care - keeping their babies' umbilical stumps clean and dry - as per normal routine standard of care and in accordance with Zambia Ministry of Health policy.

Dry cord care: Mothers will be instructed to keep their infants' umbilical cord stumps clean and dry and to not apply any foreign substances to the cord stump.

Total of all reporting groups
Overall Number of Baseline Participants 19629 20050 39679
Hide Baseline Analysis Population Description
Pregnant women attending health facilities for antenatal care
Age, Customized  
Measure Type: Number
Unit of measure:  Participants
Number Analyzed 19629 participants 20050 participants 39679 participants
<20 years 4671 4580 9251
20-35 years 12772 13122 25894
>35 years 2012 2194 4206
Missing (not recorded) 174 154 328
Sex: Female, Male  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 19629 participants 20050 participants 39679 participants
Female
19629
 100.0%
20050
 100.0%
39679
 100.0%
Male
0
   0.0%
0
   0.0%
0
   0.0%
Race/Ethnicity, Customized  
Measure Type: Number
Unit of measure:  Participants
Number Analyzed 19629 participants 20050 participants 39679 participants
Tonga 17003 17650 34653
Ila 105 121 226
Lozi 786 795 1581
Nyanja 525 432 957
Bemba 413 433 846
Other 629 481 1110
Missing (not recorded) 168 138 306
Region of Enrollment  
Measure Type: Number
Unit of measure:  Participants
Zambia Number Analyzed 19629 participants 20050 participants 39679 participants
19629 20050 39679
Maternal Education  
Measure Type: Number
Unit of measure:  Participants
Number Analyzed 19629 participants 20050 participants 39679 participants
No eduction 1936 1958 3894
Lower Primary 2293 2563 4856
Upper Primary 7731 7874 15605
Junior Secondary 5422 5499 10921
Upper Secondary 1895 1840 3735
>Upper Secondary 180 160 340
Do not know 3 10 13
Missing (not recorded) 169 146 315
Marital Status  
Measure Type: Number
Unit of measure:  Participants
Number Analyzed 19629 participants 20050 participants 39679 participants
Single 3021 3133 6154
Married 16107 16499 32606
Separated, divorced or widowed 224 187 411
Cohabiting 109 89 198
Missing (not recorded) 168 142 310
Maternal literacy  
Measure Type: Number
Unit of measure:  Participants
Number Analyzed 19629 participants 20050 participants 39679 participants
Not at all 5037 5491 10528
A bit 8835 9516 18351
Very well 5492 4835 10327
No response from mother 77 61 138
Missing (not recorded) 188 147 335
Household water source  
Measure Type: Number
Unit of measure:  Participants
Number Analyzed 19629 participants 20050 participants 39679 participants
Household tap 1861 1715 3576
Community tap 1919 1761 3680
Other water source on own property 2295 2403 4698
Community well or river 13241 13768 27009
No answer from Mother 56 62 118
Other 67 166 233
Missing (Not recorded) 190 175 365
Parity  
Mean (Standard Deviation)
Unit of measure:  Pregnancies
Number Analyzed 19629 participants 20050 participants 39679 participants
2.4  (2.3) 2.5  (2.4) 2.5  (2.4)
Gravida  
Mean (Standard Deviation)
Unit of measure:  Deliveries
Number Analyzed 19629 participants 20050 participants 39679 participants
3.5  (2.3) 3.6  (2.4) 3.6  (2.4)
Gestational Age at enrollment  
Mean (Standard Deviation)
Unit of measure:  Weeks
Number Analyzed 19629 participants 20050 participants 39679 participants
28.0  (7.2) 28.4  (7.2) 28.3  (7.2)
Slept under mosquito bednet the previous night  
Measure Type: Number
Unit of measure:  Participants
Number Analyzed 19629 participants 20050 participants 39679 participants
Yes 11092 11783 22875
No 8310 8075 16385
Missing (not recorded) 227 192 419
1.Primary Outcome
Title All-cause Neonatal Mortality
Hide Description All-cause neonatal mortality based on vital status at 28 days post-partum
Time Frame 28 days post-partum
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Chlorhexidine Cord Care Dry Cord Care
Hide Arm/Group Description:

Mothers located in health facility catchment areas assigned to this arm will apply chlorhexidine to their infants daily until three days after the cord completely separates.

Chlorhexidine gluconate (4%): Chlorhexidine is a topical antiseptic that has long been tested for safety and widely used in developed country hospitals, pre-surgical antiseptic technique, wound cleaning and disinfection. Mothers will be instructed to apply 10 ml of 4% chlorhexidine once a day following the infants bath every day from birth until three days after the cord completely separates from the infant's body.

Mothers in health facility catchment areas assigned to this arm will use dry cord care - keeping their babies' umbilical stumps clean and dry - as per normal routine standard of care and in accordance with Zambia Ministry of Health policy.

Dry cord care: Mothers will be instructed to keep their infants' umbilical cord stumps clean and dry and to not apply any foreign substances to the cord stump.

Overall Number of Participants Analyzed 18450 19308
Measure Type: Number
Unit of Measure: participants
Neonatal mortality 282 263
Survived to day 28 18168 19045
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Chlorhexidine Cord Care, Dry Cord Care
Comments [Not Specified]
Type of Statistical Test Superiority or Other (legacy)
Comments [Not Specified]
Method of Estimation Estimation Parameter Risk Ratio (RR)
Estimated Value 1.12
Confidence Interval (2-Sided) 95%
0.88 to 1.44
Estimation Comments The chlorhexidine arm is the numerator and dry cord care arm is the denominator in the relative risk calculation. Generalised estimating equation models were used to adjust for cluster randomized design.
2.Primary Outcome
Title All-cause Neonatal Mortality Among Newborns Who Survived at Least First Day of Life
Hide Description All-cause mortality by day 28 of life among newborns who survive at least the first day of life
Time Frame 28 days post-partum
Hide Outcome Measure Data
Hide Analysis Population Description
All liveborn neonates who survived the first 24 hours after delivery
Arm/Group Title Chlorhexidine Cord Care Dry Cord Care
Hide Arm/Group Description:

Mothers located in health facility catchment areas assigned to this arm will apply chlorhexidine to their infants daily until three days after the cord completely separates.

Chlorhexidine gluconate (4%): Chlorhexidine is a topical antiseptic that has long been tested for safety and widely used in developed country hospitals, pre-surgical antiseptic technique, wound cleaning and disinfection. Mothers will be instructed to apply 10 ml of 4% chlorhexidine once a day following the infants bath every day from birth until three days after the cord completely separates from the infant's body.

Mothers in health facility catchment areas assigned to this arm will use dry cord care - keeping their babies' umbilical stumps clean and dry - as per normal routine standard of care and in accordance with Zambia Ministry of Health policy.

Dry cord care: Mothers will be instructed to keep their infants' umbilical cord stumps clean and dry and to not apply any foreign substances to the cord stump.

Overall Number of Participants Analyzed 18424 19266
Measure Type: Number
Unit of Measure: neonates who survived first 24 hours
Neonatal mortality 200 186
Survived to day 28 18224 19080
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Chlorhexidine Cord Care, Dry Cord Care
Comments [Not Specified]
Type of Statistical Test Superiority or Other (legacy)
Comments [Not Specified]
Method of Estimation Estimation Parameter Risk Ratio (RR)
Estimated Value 1.12
Confidence Interval (2-Sided) 95%
0.86 to 1.47
Estimation Comments Generalized estimating equation models adjusting for cluster-randomized design were used.
3.Secondary Outcome
Title Incidence of Omphalitis
Hide Description

Omphalitis, or umbilical cord infection, defined as:

  • presence of umbilical cord pus and mild, moderate or severe redness
  • moderate or severe redness without the presence of umbilical cord pus
Time Frame 28 days postpartum
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Chlorhexidine Cord Care Dry Cord Care
Hide Arm/Group Description:

Mothers located in health facility catchment areas assigned to this arm will apply chlorhexidine to their infants daily until three days after the cord completely separates.

Chlorhexidine gluconate (4%): Chlorhexidine is a topical antiseptic that has long been tested for safety and widely used in developed country hospitals, pre-surgical antiseptic technique, wound cleaning and disinfection. Mothers will be instructed to apply 10 ml of 4% chlorhexidine once a day following the infants bath every day from birth until three days after the cord completely separates from the infant's body.

Mothers in health facility catchment areas assigned to this arm will use dry cord care - keeping their babies' umbilical stumps clean and dry - as per normal routine standard of care and in accordance with Zambia Ministry of Health policy.

Dry cord care: Mothers will be instructed to keep their infants' umbilical cord stumps clean and dry and to not apply any foreign substances to the cord stump.

Overall Number of Participants Analyzed 18510 19346
Measure Type: Number
Unit of Measure: neonates
Omphalitis 82 118
No omphalitis 18428 19228
Hide Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Chlorhexidine Cord Care, Dry Cord Care
Comments [Not Specified]
Type of Statistical Test Superiority or Other (legacy)
Comments [Not Specified]
Method of Estimation Estimation Parameter Risk Ratio (RR)
Estimated Value 0.73
Confidence Interval (2-Sided) 95%
0.47 to 1.13
Estimation Comments Generalized estimating equation models adjusting for cluster-randomized design were used.
4.Secondary Outcome
Title Place of Delivery
Hide Description The location where mothers gave birth (home versus a health facility) will be compared to their planned delivery location.
Time Frame 28 days postpartum
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title Chlorhexidine Cord Care Dry Cord Care
Hide Arm/Group Description:

Mothers located in health facility catchment areas assigned to this arm will apply chlorhexidine to their infants daily until three days after the cord completely separates.

Chlorhexidine gluconate (4%): Chlorhexidine is a topical antiseptic that has long been tested for safety and widely used in developed country hospitals, pre-surgical antiseptic technique, wound cleaning and disinfection. Mothers will be instructed to apply 10 ml of 4% chlorhexidine once a day following the infants bath every day from birth until three days after the cord completely separates from the infant's body.

Mothers in health facility catchment areas assigned to this arm will use dry cord care - keeping their babies' umbilical stumps clean and dry - as per normal routine standard of care and in accordance with Zambia Ministry of Health policy.

Dry cord care: Mothers will be instructed to keep their infants' umbilical cord stumps clean and dry and to not apply any foreign substances to the cord stump.

Overall Number of Participants Analyzed 18510 19346
Measure Type: Count of Participants
Unit of Measure: Participants
Home Delivery
6509
  35.2%
6682
  34.5%
Facility Delivery
11456
  61.9%
12204
  63.1%
Other
190
   1.0%
128
   0.7%
Missing
355
   1.9%
332
   1.7%
5.Secondary Outcome
Title Factors Influencing Delivery Location
Hide Description Health facility characteristics and maternal decision making factors that influence choice of delivery location (health facility vs. home delivery)
Time Frame 28 days postpartum
Hide Outcome Measure Data
Hide Analysis Population Description
Women enrolled in the ZamCAT study and delivery location known. Please note these are different denominators reported as this analysis is not based on intervention randomization, but rather an analysis focused on women's location of childbirth. Therefore, the number of women included in this analysis is based on a subset of all women enrolled.
Arm/Group Title Facility Delivery Home Delivery
Hide Arm/Group Description:
Women who enrolled in ZamCAT study and delivered at a facility
Women who enrolled in ZamCAT study and delivered at home
Overall Number of Participants Analyzed 23815 13255
Measure Type: Count of Participants
Unit of Measure: Participants
Same Location as Prior Delivery
3198
  13.4%
2082
  15.7%
Need for Skilled Attendance12991
12991
  54.5%
5693
  42.9%
Financial Constraints
1823
   7.7%
1249
   9.4%
Physical Distance
6345
  26.6%
3930
  29.6%
Relationship with Provider
572
   2.4%
429
   3.2%
Family/Social Expectations
1255
   5.3%
990
   7.5%
Safety for Mother/Baby
14129
  59.3%
5911
  44.6%
Other
1480
   6.2%
803
   6.1%
Missing
1364
   5.7%
770
   5.8%
6.Secondary Outcome
Title Health Facility Characteristics
Hide Description Characterization of the health services available to pregnant women, postpartum women and their offspring as assessed by comprehensive health facility and health worker surveys. This data was assessed and reported on 100 facilities (10 district hospitals and 90 health facilities).
Time Frame 12 months after study initiation
Hide Outcome Measure Data
Hide Analysis Population Description
Health facilities
Arm/Group Title Study Health Facilities & Hospitals
Hide Arm/Group Description:
90 health facilities and 10 district hospitals were included in the main chlorhexidine trial. A survey was completed to assess availability of emergency obstetric care.
Overall Number of Participants Analyzed 39679
Overall Number of Units Analyzed
Type of Units Analyzed: Health facilities
100
Measure Type: Number
Unit of Measure: Health facilities
Basic emergency obstetrical and newborn care 6
No basic emergency obstetrical and newborn care 94
Time Frame Adverse event data were collected during the 1 month follow up period past delivery.
Adverse Event Reporting Description Umbilical cord was observed by the field data collector at every visit (day 1, 4, 10, 28 post-partum). Adverse events were defined as ocular exposure to chlorhexidine, local skin irritation, accidental ingestion, contact dermatitis, or anaphylaxis.
 
Arm/Group Title Chlorhexidine Cord Care Dry Cord Care
Hide Arm/Group Description

Mothers located in health facility catchment areas assigned to this arm will apply chlorhexidine to their infants daily until three days after the cord completely separates.

Chlorhexidine gluconate (4%): Chlorhexidine is a topical antiseptic that has long been tested for safety and widely used in developed country hospitals, pre-surgical antiseptic technique, wound cleaning and disinfection. Mothers will be instructed to apply 10 ml of 4% chlorhexidine once a day following the infants bath every day from birth until three days after the cord completely separates from the infant's body.

Mothers in health facility catchment areas assigned to this arm will use dry cord care - keeping their babies' umbilical stumps clean and dry - as per normal routine standard of care and in accordance with Zambia Ministry of Health policy.

Dry cord care: Mothers will be instructed to keep their infants' umbilical cord stumps clean and dry and to not apply any foreign substances to the cord stump.

All-Cause Mortality
Chlorhexidine Cord Care Dry Cord Care
Affected / at Risk (%) Affected / at Risk (%)
Total   282/18510 (1.52%)      263/19346 (1.36%)    
Hide Serious Adverse Events
Chlorhexidine Cord Care Dry Cord Care
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total   0/18510 (0.00%)      0/19346 (0.00%)    
Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
Chlorhexidine Cord Care Dry Cord Care
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total   9/18510 (0.05%)      0/19346 (0.00%)    
Eye disorders     
Chlorhexidine ocular exposure *  1/18510 (0.01%)  1 0/19346 (0.00%)  0
Skin and subcutaneous tissue disorders     
Chlorhexidine-related adverse events   8/18510 (0.04%)  8 0/19346 (0.00%)  0
*
Indicates events were collected by non-systematic assessment
Indicates events were collected by systematic assessment
Only 89% (37 856 of 42 570) of the target sample size was attained. When we completed a post-hoc power calculation with the obtained sample size and observed Neonatal Mortality Rate (NMR), we had 80% power to detect a 28% reduction in NMR.
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Katherine Semrau (Epidemiologist, co-PI)
Organization: Ariadne Labs|BWH & HSPH
Phone: 6177805311
EMail: ksemrau@ariadnelabs.org
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Boston University
ClinicalTrials.gov Identifier: NCT01241318    
Other Study ID Numbers: H-29647
First Submitted: November 12, 2010
First Posted: November 16, 2010
Results First Submitted: December 9, 2016
Results First Posted: May 3, 2019
Last Update Posted: August 31, 2020